Skip to main content
SpringerLink
Log in

Pharmacodynamics of Acarbose: Clinical Investigations

  • Conference paper
Acarbose for the Treatment of Diabetes Mellitus

  • 93 Accesses

Abstract

The pharmacodynamics of the microbial α-glucosidase inhibitor acarbose (Fig. 1) (BAY g 5421; Glucobay) have been investigated in a large number of clinical studies. Several of these have already been reported on at the first international symposium on acarbose (Creutzfeldt 1982), others have been carried out more recently. Both theoretical and practical aspects of the pharmacodynamics of acarbose have been investigated in volunteers and diabetics, the number of studies of theoretical aspects decreasing with time and of practical aspects increasing with time.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Anderson IH, Levine AS, Levitt MD (1981) Incomplete absorption of the carbohydrate in allpurpose wheat flour. N Engl J Med 304:891–892

    Article  PubMed  CAS  Google Scholar 

  • Bedine MS, Bayless TM (1973) Intolerance of small amounts of lactose by individuals with low lactase levels. Gastroenterology 65:735–743

    PubMed  CAS  Google Scholar 

  • Caspary WF (1978) Sucrose malabsorption in man after ingestion of α-glucosidase-hydrolase inhibitor. Lancet ii: 1231–1233

    Article  Google Scholar 

  • Caspary WF, Graf S (1979) Inhibition of human intestinal α-glucosidehydrolases by a new complex oligosaccharide. Res Exp Med 75:1–6

    Article  Google Scholar 

  • Caspary WF, Kalisch H (1978) Effect of α-glucosidehydrolase inhibition on intestinal absorption of sucrose, water, and sodium in man. Gut 20:750–755

    Article  Google Scholar 

  • Christopher NL, Bayless TM (1971) Role of the small bowel and colon in lactose-induced diarrhea. Gastroenterology 60:845–852

    PubMed  CAS  Google Scholar 

  • Creutzfeldt W (ed) (1982) First international symposium on acarbose. Excerpta Medica, Amsterdam

    Google Scholar 

  • Creutzfeldt W, Ebert R (1986) The enteroinsular axis. In: Go VLW, Gardner JP, DiMagno EP, Scheele GA (eds) The exocrine pancreas: biology, pathobiology, and diseases. Raven, New York, pp 279–286

    Google Scholar 

  • DeFronzo R, Ferrannini E, Hendler R, Wahren J, Felig P (1978) Influence of hyperinsulinaemia, hyperglycemia, and the route of glucose administration on splanchnic glucose exchange. Proc Natl Acad Sci USA 75:5173–5177

    Article  PubMed  CAS  Google Scholar 

  • Dimitriadis G, Tessari P, Go V, Gerich J (1982) Effects of the disaccharidase inhibitor acarbose on meal and intravenous glucose tolerance in normal man. Metabolism 31:841–843

    Article  PubMed  CAS  Google Scholar 

  • Fölsch UR, Ebert R, Creutzfeldt W (1981) Response of serum levels of gastric inhibitory polypeptide and insulin to sucrose ingestion during long-term application of acarbose. Scand J Gastroenterol 16:629–632

    Article  PubMed  Google Scholar 

  • Fölsch UR, Lembcke B, Börger D, v Baumbach A, Kirchhoff S, Creutzfeldt W (1987) Dosisvergleich zwischen den α-Glukosidaseinhibitoren BAYg5421 (Acarbose) und BAYml099 (Miglitol) nach wiederholter Stärke- oder Saccharosebelastung (Abstract). Aktuel Endokrinol Stoffw 8:77

    Google Scholar 

  • Gerard J, Jandrain B, Pirnay F, Pallikarakis N, Krzentowski G, Lacroix M, Mosora F, Luyckx AS, Lefebvre PJ (1986) Utilization of oral sucrose load during exercise in humans. Effect of the α-glucosidase inhibitor acarbose. Diabetes 35:1294–1301

    Article  PubMed  CAS  Google Scholar 

  • Groop P-H, Groop L, Tötterman KJ, Fyhrquist F (1986) Effects of acarbose on the relationship between changes in GIP and insulin responses to meals in normal subjects. Acta Endocrinol 112:361–366

    PubMed  CAS  Google Scholar 

  • Hagel HJ, Ruppin H, Pichel J, Feuerbach W, Bloom S, Domschke W (1985) Mode of action of the α-glucosidase inhibitor acarbose (BAY g 5421) in the small bowel. A perfusion study in man (Abstract). Diabetes Res Clin Pract Suppl 1:215

    Google Scholar 

  • Hayakawa T, Noda A, Kondo T, Okumura N (1984) Effects of acarbose, an α-glucosidase inhibitor (BAY g 5421), on orally loaded glucose, maltose and sucrose and on blood glucose control in non-insulin-dependent diabetics. Nagoya J Med Sci 47:35–41

    Google Scholar 

  • Hillebrand I, Boehme K, Frank G, Fink H, Berchtold P (1979 a) The effects of the α-glucosidase inhibitor BAY g 5 421 (Acarbose) on meal-stimulated elevations of circulating glucose, insulin, and triglyceride levels in man. Res Exp Med (Berl) 175:81–86

    Article  CAS  Google Scholar 

  • Hillebrand I, Boehme K, Frank G, Fink H, Berchtold P (1979b) The effects of the α-glucosidase inhibitor BAY g 5 421 (Acarbose) on postprandial blood glucose, serum insulin and triglyceride levels: dose-time-response relationships in man. Res Exp Med (Berl) 175:87–94

    Article  CAS  Google Scholar 

  • Homma Y, Irie N, Yano Y, Nakaya N, Goto Y (1982) Changes in plasma lipoprotein levels during medication with a glucoside-hydrolase inhibitor (acarbose). Tokai J Exp Clin Med 7:393–396

    PubMed  CAS  Google Scholar 

  • Jain NK, Rosenberg DB, Ulahannan MJ, Glasser MJ, Pitchumoni CS (1985) Sorbitol intolerance in adults. Am J Gastroenterol 80:678–681

    PubMed  CAS  Google Scholar 

  • Jandrain B, Gerard J, Verdin E, Luyckx AS, Lefebvre PJ (1985) Effect of acarbose on the hormonal and metabolic response to the simultaneous ingestion of sucrose and ethanol (Abstract). Diabetes Res Clin Pract Suppl 1:267

    Google Scholar 

  • Jenkins DJA, Taylor RH, Goff DV, Fielden H, Misiewicz JJ, Sarson DL, Bloom SR, Alberti KGMM (1981) Scope and specificity of acarbose in slowing carbohydrate absorption in man. Diabetes 30:951–954

    Article  PubMed  CAS  Google Scholar 

  • Ladas S, Papanikos J, Arapakis G (1982) Lactose malabsorption in greek adults: correlation of small bowel transit time with the severity of lactose intolerance. Gut 23:968–973

    Article  PubMed  CAS  Google Scholar 

  • Lebovitz HE (1987) Type II diabetes mellitus: a treatment dilemma. Am J Med 83 (Suppl 3A): 1–2

    Article  PubMed  CAS  Google Scholar 

  • Lembcke B (1982) Physiologie und Pathophysiologie des Dünn- und Dickdarmes. Ernährungsumschau 29:457–465

    Google Scholar 

  • Lembcke B (1987) Untersuchungen zur medikamentösen Beeinflussung der intestinalen Kohlenhy-dratassimilation. Ein Beitrag zum Therapieprinzip Resorptionsverzögerung. Habilitationsschrift, Georg-August-University Göttingen

    Google Scholar 

  • Lembcke B, Caspary WF (1983) Atemanalytische Funktionstests. In: Caspary WF (ed) Handbuch der Inneren Medizin, vol 3/3A, Dünndarm. Springer, Berlin Heidelberg New York, pp 488–520

    Google Scholar 

  • Levitt MD (1983) Malabsorption of starch: a normal phenomenon (Editorial). Gastroenterology 85:769–770

    PubMed  CAS  Google Scholar 

  • Puls W (1980) Zur Inhibition intestinaler Glukosidasen — Ein neues Prinzip zur Prävention und Therapie von kohlenhydratabhängigen Stoffwechselerkrankungen. Habilitationsschrift, University of Düsseldorf

    Google Scholar 

  • Puls W, Keup U, Krause HP, Thomas G, Hoffmeister F (1977) Glucosidase inhibition. A new approach to the treatment of diabetese, obesity, and hyperlipoproetinaemia. Naturwissenschaften 64:536

    Article  PubMed  CAS  Google Scholar 

  • Radziuk J, Kemmer F, Morishima T, Berchtold P, Vranic M (1984) The effects of an alpha-glucoside hydrolase inhibitor on glycemia and the absorption of sucrose in man determined using a tracer method. Diabetes 33:207–213

    Article  PubMed  CAS  Google Scholar 

  • Raptis S, Dimitriadis G, Etzrodt H, Karaiskos C, Hadjidakis D, Rosenthal J, Zoupas C, Diamantopoulos E (1982) The effects of acarbose treatment on release of pancreatic and gastro-intestinal hormones in man. In: Creutzfeldt W (ed) First international symposium on acarbose. Excerpta Medica, Amsterdam, pp 210–215

    Google Scholar 

  • Rating D, Gryzewski N, Burger W, Kneer J, Weber B, Helge H (1982) The modification of sucrose absorption by acarbose. In: Creutzfeldt W (ed) First international symposium on acarbose. Excerpta Medica, Amsterdam, pp 252–257

    Google Scholar 

  • Ravich WJ, Bayless TM, Thomas M (1983) Fructose: incomplete intestinal absorption in humans. Gastroenterology 84:26–29

    PubMed  CAS  Google Scholar 

  • Suehiro I, Otsuki M, Yamasaki T, Ohki A, Sakamoto C, Yuu H, Maeda M, Baba S (1981) Effect of α-glucosidase inhibitor on human pancreatic and salivary amylase. Clin Chim Acta 117:145–152

    Article  PubMed  CAS  Google Scholar 

  • Taylor RH, Jenkins DJA, Barker HM, Fielden H, Goff DV, Misiewicz JJ, Lee DA, Brian Allen H, MacDonald G, Wallrabe H (1982) Effect of acarbose on the 24-hour blood glucose profile and pattern of carbohydrate absorption. Diabetes Care 5:92–96

    Article  PubMed  CAS  Google Scholar 

  • Uttenthal LO, Ukponmwan OO, Ghiglione M, Bloom SR (1987) Acute and short term effect of intestinal alpha-glucosidase inhibition on gut hormone responses in man. Dig Dis Sci 32:139–144

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Gastroenterology, Centre of Internal Medicine Johann-Wolfgang-Goethe-Universität, Theodor-Stern-Kai 7, D-6000, Frankfurt 70, Germany

    B. Lembcke

Authors
  1. B. Lembcke
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Abteilung Gastroenterologie und Endokrinologie Zentrum Innere Medizin, Georg-August-Universität Göttingen, Robert-Koch-Str. 40, 3400, Göttingen, Germany

    W. Creutzfeldt

Rights and permissions

Reprints and permissions

Copyright information

© 1988 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Lembcke, B. (1988). Pharmacodynamics of Acarbose: Clinical Investigations. In: Creutzfeldt, W. (eds) Acarbose for the Treatment of Diabetes Mellitus. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-73583-7_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-73583-7_8

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-19145-2

  • Online ISBN: 978-3-642-73583-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation